Stay updated with breaking news from Bio Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sibylla Biotech today announced the successful close of its €23 million Series A financing round to fund the further development of its Pharmacological Protein Inactivation by Folding Intermediate
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform Closing on € 30 million, AstriVax has raised the largest amount of...
Nano-X Imaging Ltd. (NASDAQ:NASDAQ:NNOX) Q2 2022 Earnings Conference Call August 16, 2022 8:30 AM ET Company Participants Mike Cavanaugh - Managing Director of Investor Relations Erez...
NNOX earnings call for the period ending June 30, 2022.